U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta - Physician's Weekly
U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta Physician's Weekly
Aug 29, 2019 | Reuters | 0 |. (Reuters) – The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of Eli ...
Comments
Post a Comment